Aligos Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 444.11 K | $3.30 M | 0.00% | 4.49% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 412.00 K | $3.06 M | 0.00% | 4.17% |
| SIO CAPITAL MANAGEMENT, LLC | 05/14/2026 | 327.24 K | $2.43 M | -2.59% | 3.31% |
| MARSHALL WACE, LLP | 05/15/2026 | 267.14 K | $1.98 M | -0.57% | 2.70% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 229.75 K | $1.71 M | 1,652.78% | 2.32% |
| 05/15/2026 | 178.26 K | $1.32 M | 100.00% | 1.80% | |
| WOODLINE PARTNERS LP | 05/15/2026 | 177.36 K | $1.32 M | -38.66% | 1.79% |
| SUMMITTX CAPITAL, L.P. | 05/15/2026 | 148.80 K | $1.11 M | 6.72% | 1.51% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 100.45 K | $746.34 K | 17.56% | 1.02% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 83.06 K | $617.10 K | 0.00% | 0.84% |
| HHLR ADVISORS, LTD. | 05/15/2026 | 76.25 K | $566.52 K | 0.00% | 0.77% |
| CITADEL ADVISORS LLC | 05/15/2026 | 54.31 K | $403.53 K | 4.78% | 0.55% |
| LPL FINANCIAL LLC | 05/06/2026 | 51.50 K | $382.65 K | -21.97% | 0.52% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 49.98 K | $371.47 K | 4.68% | 0.51% |
| UBS GROUP AG | 05/05/2026 | 37.06 K | $275.36 K | 10,081.59% | 0.37% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 28.44 K | $211.29 K | 100.00% | 0.29% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 23.09 K | $171.58 K | -71.37% | 0.23% |
| VERITION FUND MANAGEMENT LLC | 05/15/2026 | 18.89 K | $140.33 K | -73.49% | 0.19% |
| XTX TOPCO LTD | 05/15/2026 | 14.20 K | $105.48 K | -38.42% | 0.14% |
| BLACKROCK, INC. | 05/13/2026 | 13.04 K | $96.89 K | 0.00% | 0.13% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 10.98 K | $81.57 K | 100.00% | 0.11% |
| QUADRATURE CAPITAL LTD | 05/15/2026 | 10.82 K | $80.41 K | 100.00% | 0.11% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 05/14/2026 | 10.00 K | $74.30 K | 0.00% | 0.10% |
| GOLDEN STATE WEALTH MANAGEMENT, LLC | 04/28/2026 | 2.67 K | $19.87 K | 0.00% | 0.03% |
| ROYAL BANK OF CANADA | 05/15/2026 | 2.13 K | $16.00 K | 0.00% | 0.02% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/14/2026 | 950 | $7.06 K | 100.00% | 0.01% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 936 | $6.95 K | 100.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 700 | $5.20 K | -53.33% | 0.01% |
| JPMORGAN CHASE & CO | 05/13/2026 | 674 | $4.42 K | 120.26% | 0.01% |
| MORGAN STANLEY | 05/15/2026 | 218 | $1.62 K | -91.35% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 65 | $483 | 66.67% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 26 | $193 | 0.00% | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 04/14/2026 | 4 | $30 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 3 | $22 | 0.00% | 0.00% |
| FMR LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| CLEAR STREET MARKETS LLC | 04/30/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| NORTHCREST ASSET MANANGEMENT, LLC | 04/08/2026 | 0 | $0 | -100.00% | 0.00% |
Aligos Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 49 institutional investors and hedge funds held shares of Aligos Therapeutics Inc. The most heavily invested institutionals were:
Deep Track Capital, LP: 444,110
Alyeska Investment Group, L.P.: 412,000
Sio Capital Management, LLC: 327,237
MARSHALL WACE, LLP: 267,135
BANK OF AMERICA CORP /DE/: 229,754
Woodline Partners LP: 177,362
28.07% of Aligos Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 6.09 M shares in the last 24 months. This purchase volume represents approximately $42.84 M in transactions.